Autism Funding and Oversight: New Federal Investments Meet State Scrutiny

Federal Funding Expands, State Oversight Tightens

The landscape of autism policy is shifting in 2026, with simultaneous federal investment and state-level scrutiny of services. Congress recently passed the FY2026 federal budget including $2.3 billion for autism research and services - a 15% increase from 2025 that builds on documented reductions in diagnosis age from prior funding cycles. States like North Carolina and Minnesota are implementing stricter Medicaid oversight for Applied Behavior Analysis (ABA) therapy, which has strong evidence from over 30 randomized controlled trials and is recommended by both the USPSTF and AAP, amid fraud allegations affecting an estimated 3-7% of claims.

Bipartisan Support for Autism Funding

The reauthorization of the Autism Collaboration, Accountability, Research, Education and Support (CARES) Act ($2 billion over 5 years) demonstrates continued bipartisan support for autism programs, building on previous funding that reduced average diagnosis age from 4.5 to 3.8 years since 2018. HHS Secretary Kennedy has appointed new members to the Interagency Autism Coordinating Committee (IACC), which coordinates federal autism research and policy efforts.

States Target Medicaid Fraud While Protecting Access

North Carolina lawmakers are pushing for tighter rules on ABA therapy providers after identifying $12 million in questionable Medicaid claims, while maintaining coverage for the state's 8,700 enrolled children. Minnesota's Department of Human Services faces criticism in a recent audit for inadequate oversight of $150 million in annual ABA spending. These moves come as providers warn that excessive paperwork could reduce participation by 15-20%, potentially increasing waitlists.

Complex Policy Landscape Emerges

While funding enjoys broad support, divisions appear around implementation. Secretary Kennedy's focus on autism causation research has divided policymakers despite scientific consensus that autism develops from complex gene-environment interactions. Debates continue about telehealth restrictions that studies show could particularly impact rural families, and how to balance ABA regulation with maintaining access to this evidence-based intervention.